<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">Esophageal cancer</z:e> (EC) is a deadly disease </plain></SENT>
<SENT sid="1" pm="."><plain>EC usually occurs as either <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EAC) or <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The development of EAC generally follows the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) is a metasplastic precursor of EAC </plain></SENT>
<SENT sid="4" pm="."><plain>Multiple global miRNA expression profiling and candidate gene studies have been performed in EAC and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> that clearly support the important roles of miRNAs in the pathogenesis of EAC and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A number of consistently dysregulated miRNAs have been identified in EAC and/or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e>, including upregulation of miR-21, miR-192, miR-194, miR-106-25 polycistron (miR-25, miR-93, and miR-106b), miR-10b, miR-151, and miR-93, and downregulation of miR-375, miR-203, miR-205, miR-145, miR- 27b, miR-100, miR-125b, let-7c, etc </plain></SENT>
<SENT sid="6" pm="."><plain>Most of these miRNAs are also dysregulated in other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types and their target genes have been extensively studied in different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The prognostic value of miR-21 and miR-375 has been replicated in independent studies </plain></SENT>
<SENT sid="8" pm="."><plain>Circulating miRNAs as potential biomarkers for early detection, prognosis, and treatment response have only been scarcely studied in EC </plain></SENT>
<SENT sid="9" pm="."><plain>The association of genetic variations in miRNA regulatory pathway with EC risk or outcome is a largely uncharted territory </plain></SENT>
<SENT sid="10" pm="."><plain>Future studies should be focused on the role of miRNAs in the prognosis of EC, the identification of circulating miRNAs and miRNA-related genetic variations as biomarkers in EC, and the biological mechanisms underlying the contribution of miRNA dysreguation to EC </plain></SENT>
<SENT sid="11" pm="."><plain>A better understanding of roles of miRNA in EC developemnt may provide new avenues for the early detection, diagnosis, prognosis, and therapy of this deadly disease </plain></SENT>
</text></document>